Header image  


Isis Pharmaceuticals Reports Data from ISIS-SMN Rx Phase 2 Study in Infants with Spinal Muscular Atrophy - June 2015

Canadian SMA Research News

FSMAC has been supporting the best in Canadian SMA research since 2001. Below are some of the current projects we fund.

2015 Research News

Project update for FSMA Canada -- The Non‐SMN Mediated Benefits of The HDAC Inhibitor Trichostatin A. PI: Rashmi Kothary - Feb 2015

Arginine Methylation as a Regulator of SMN activities in Motor Neurons - Jocelyn Côté, Ph.D. - Feb 2015

2014 Clinical Trial News (there are 3 Canadian locations)

Identification and Characterization of Factors Critical in Regulating the Selective Vulnerability of Distinct Motor neuron Pools in Spinal Muscular Atrophy Models of Mice - May 6, 2013

Clinical Trial for Type 1 Infants - Toronto Sick Kids - April 26, 2013

Families of SMA Canada funds a New Research Project by Dr. Jocelyn Cote from the University of Ottawa for $140,000 (2013)

Canadian Neuromuscular Disease Registry (CNDR) and SMA (2012)


For American and International SMA research News, go to the FSMA-US Research News section.